骨水泥型与生物型全髋关节置换术后早期死亡风险的全国配对队列研究
基于瑞典髋关节置换登记册的全国配对队列研究,纳入178 784例骨关节炎全髋关节置换患者并与862 294名普通人群对照配对。骨水泥型全髋置换患者术后前14天死亡风险高于对照(HR 1.3,CI 1.11至1.44),绝对风险增加为每10 000例观察中5例死亡;生物型全髋置换未见此早期风险升高。第15至29天骨水泥型死亡风险降低(HR 0.7,CI 0.62至0.87),第30至90天所有全髋置换患者死亡风险均低于对照。
要点
- 骨水泥型全髋置换术后前14天死亡风险高于普通人群对照(HR 1.3,CI 1.11至1.44),绝对风险增加为每10 000例观察中5例死亡。
- 生物型全髋置换术后未见早期死亡风险升高。
- 第15至29天骨水泥型全髋置换死亡风险低于对照(HR 0.7,CI 0.62至0.87),第30至90天所有全髋置换患者死亡风险均低于对照。
核心结论
- 该全国配对队列研究提示,接受骨水泥型全髋关节置换的患者早期死亡相对风险轻微升高,自第15天起转为降低,绝对风险增加非常小。
- 研究结果支持股骨假体骨水泥固定比髋臼假体骨水泥固定更危险这一观点。
研究设计与样本
- 全国配对队列研究,纳入瑞典髋关节置换登记册中因骨关节炎行骨水泥型或生物型全髋关节置换的178 784例患者,并与862 294名普通人群对照配对,调整年龄、合并症和社会经济背景。
- 主要结局指标为术后前90天内死亡率;补充分析纳入16 556例混合型全髋关节置换。
主要发现
- 骨水泥型全髋置换患者术后前14天死亡风险高于对照(HR 1.3,CI 1.11至1.44),绝对风险增加为每10 000例观察中5例死亡;生物型全髋置换未见此早期风险升高。
- 第15至29天骨水泥型全髋置换死亡风险低于对照(HR 0.7,CI 0.62至0.87)。
- 第30至90天所有全髋置换患者不论固定方式死亡风险均低于对照。
- 选择生物型固定的患者比选择骨水泥型固定的患者更年轻、更健康、教育水平和收入更高。
- 补充分析16 556例混合型全髋置换提示,股骨假体骨水泥固定与15天内死亡率轻度升高相关,而骨水泥型髋臼假体联合生物型股骨假体未见此死亡风险升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: It has been suggested that cemented fixation of total hip arthroplasty (THA) is associated with an increased peri-operative mortality compared with cementless THA. Our aim was to investigate this through a nationwide matched cohort study adjusting for age, comorbidity, and socioeconomic background. PATIENTS AND METHODS: A total of 178 784 patients with osteoarthritis who underwent either cemented or cementless THA from the Swedish Hip Arthroplasty Register were matched with 862 294 controls from the general population. Information about the causes of death, comorbidities, and socioeconomic background was obtained. Mortality within the first 90 days after the operation was the primary outcome measure. RESULTS: Patients who underwent cemented THA had an increased risk of death during the first 14 days compared with the controls (hazard ratio (HR) 1.3, confidence interval (CI) 1.11 to 1.44), corresponding to an absolute increase in risk of five deaths per 10 000 observations. No such early increase of risk was seen in those who underwent cementless THA. Between days 15 and 29 the risk of mortality was decreased for those with cemented THA (HR 0.7, CI 0.62 to 0.87). Between days 30 and 90 all patients undergoing THA, irrespective of the mode of fixation, had a lower risk of death than controls. Patients selected for cementless fixation were younger, healthier and had a higher level of education and income than those selected for cemented THA. A supplementary analysis of 16 556 hybrid THAs indicated that cementation of the femoral component was associated with a slight increase in mortality up to 15 days, whereas no such increase in mortality was seen in those with a cemented acetabular component combined with a cementless femoral component. CONCLUSION: This nationwide matched cohort study indicates that patients receiving cemented THA have a minimally increased relative risk of early mortality that is reversed from day 15 and thereafter. The absolute increase in risk is very small. Our findings lend support to the idea that cementation of the femoral component is more dangerous than cementation of the acetabular component. Cite this article: Bone Joint J 2017;99-B:37-43.
引用
- Garland A, Gordon M, Garellick G, et al. Risk of early mortality after cemented compared with cementless total hip arthroplasty: a nationwide matched cohort study. Bone Joint J. 2017. PMID: 28053255. doi:10.1302/0301-620X.99B1.BJJ-2016-0304.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。